Vincent Medical Holdings Ltd Profitability Analysis: Past Growth, Margins, Return on Capital, Free Cash Flow, and more - Vincent Medical Holdings Ltd - Alpha Spread

Vincent Medical Holdings Ltd
HKEX:1612

Watchlist Manager
Vincent Medical Holdings Ltd Logo
Vincent Medical Holdings Ltd
HKEX:1612
Watchlist
Price: 0.414 HKD Market Closed
Market Cap: 270.5m HKD
Have any thoughts about
Vincent Medical Holdings Ltd?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Vincent Medical Holdings Ltd

Revenue
737.4m HKD
Cost of Revenue
-496.7m HKD
Gross Profit
240.7m HKD
Operating Expenses
-173.4m HKD
Operating Income
67.4m HKD
Other Expenses
-3.4m HKD
Net Income
64m HKD

Margins Comparison
Vincent Medical Holdings Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
HK
Vincent Medical Holdings Ltd
HKEX:1612
270.5m HKD
33%
9%
9%
US
Abbott Laboratories
NYSE:ABT
198.1B USD
55%
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
167.6B USD
67%
26%
28%
US
Stryker Corp
NYSE:SYK
136.8B USD
64%
22%
16%
US
Boston Scientific Corp
NYSE:BSX
120B USD
69%
18%
12%
IE
Medtronic PLC
NYSE:MDT
115.3B USD
66%
19%
12%
US
Becton Dickinson and Co
NYSE:BDX
67.3B USD
45%
15%
7%
DE
Siemens Healthineers AG
XETRA:SHL
56.4B EUR
38%
12%
8%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
292.8B CNY
65%
35%
34%
US
Edwards Lifesciences Corp
NYSE:EW
40.3B USD
77%
28%
25%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.9B USD
41%
13%
8%
Country HK
Market Cap 270.5m HKD
Gross Margin
33%
Operating Margin
9%
Net Margin
9%
Country US
Market Cap 198.1B USD
Gross Margin
55%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 167.6B USD
Gross Margin
67%
Operating Margin
26%
Net Margin
28%
Country US
Market Cap 136.8B USD
Gross Margin
64%
Operating Margin
22%
Net Margin
16%
Country US
Market Cap 120B USD
Gross Margin
69%
Operating Margin
18%
Net Margin
12%
Country IE
Market Cap 115.3B USD
Gross Margin
66%
Operating Margin
19%
Net Margin
12%
Country US
Market Cap 67.3B USD
Gross Margin
45%
Operating Margin
15%
Net Margin
7%
Country DE
Market Cap 56.4B EUR
Gross Margin
38%
Operating Margin
12%
Net Margin
8%
Country CN
Market Cap 292.8B CNY
Gross Margin
65%
Operating Margin
35%
Net Margin
34%
Country US
Market Cap 40.3B USD
Gross Margin
77%
Operating Margin
28%
Net Margin
25%
Country US
Market Cap 38.9B USD
Gross Margin
41%
Operating Margin
13%
Net Margin
8%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Vincent Medical Holdings Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
HK
Vincent Medical Holdings Ltd
HKEX:1612
270.5m HKD
12%
9%
12%
12%
US
Abbott Laboratories
NYSE:ABT
198.1B USD
15%
8%
11%
9%
US
Intuitive Surgical Inc
NASDAQ:ISRG
167.6B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
136.8B USD
19%
9%
15%
11%
US
Boston Scientific Corp
NYSE:BSX
120B USD
9%
5%
9%
7%
IE
Medtronic PLC
NYSE:MDT
115.3B USD
8%
4%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
67.3B USD
5%
3%
6%
6%
DE
Siemens Healthineers AG
XETRA:SHL
56.4B EUR
11%
4%
8%
5%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
292.8B CNY
36%
25%
34%
46%
US
Edwards Lifesciences Corp
NYSE:EW
40.3B USD
21%
15%
20%
21%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.9B USD
21%
5%
10%
6%
Country HK
Market Cap 270.5m HKD
ROE
12%
ROA
9%
ROCE
12%
ROIC
12%
Country US
Market Cap 198.1B USD
ROE
15%
ROA
8%
ROCE
11%
ROIC
9%
Country US
Market Cap 167.6B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 136.8B USD
ROE
19%
ROA
9%
ROCE
15%
ROIC
11%
Country US
Market Cap 120B USD
ROE
9%
ROA
5%
ROCE
9%
ROIC
7%
Country IE
Market Cap 115.3B USD
ROE
8%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 67.3B USD
ROE
5%
ROA
3%
ROCE
6%
ROIC
6%
Country DE
Market Cap 56.4B EUR
ROE
11%
ROA
4%
ROCE
8%
ROIC
5%
Country CN
Market Cap 292.8B CNY
ROE
36%
ROA
25%
ROCE
34%
ROIC
46%
Country US
Market Cap 40.3B USD
ROE
21%
ROA
15%
ROCE
20%
ROIC
21%
Country US
Market Cap 38.9B USD
ROE
21%
ROA
5%
ROCE
10%
ROIC
6%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top